LY2886721 is an BACE inhibitor used for the treatment of Alzheimers Disease. IC50 value: Target: BACE LY2886721 is a novel potent agent that is used to treat Alzheimers Disease in preclinical experiments. LY2886721 is under clinical study. A Safety Study of LY2886721 Multiple Doses is performing in Healthy Subjects.
Puffer:
Powder
CAS Nummer:
[1262036-50-9]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten